Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness and Choroidal Vascularity Index in Emmetropes

NCT05617794 is registered in ClinicalTrials.gov with SightGlass Vision, Inc. as lead sponsor.

NCT NCT05617794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05617794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness and Choroidal Vascularity Index in Emmetropes
Lead sponsor
SightGlass Vision, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 18, 2023
Completion date
December 31, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

juvenile myopia, myopia, myopia progression